Enhancer of zeste homolog 2: A potential target for tumor therapy

被引：31

作者：

Xiao, Yongtao ^{[1
]}

机构：

[1] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China

来源：

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2011年 / 43卷 / 04期

关键词：

Enhancer of zeste homolog 2; H3K27; Methylation; Phosphorylation; Cancer therapy; GROUP PROTEIN EZH2; MALIGNANT MYELOID DISORDERS; H3; LYSINE-27; METHYLATION; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; CRITICAL REGION; GENE; EXPRESSION; MECHANISMS; BLADDER;

D O I：

10.1016/j.biocel.2011.01.005

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Enhancer of zeste homolog 2 (EZH2) is a subunit of the Polycomb-Repressive Complex 2 (PRC2), which catalyses the trimethylation of histone H3 on Lys 27 (H3K27) and involves in genes repression. EZH2 is amplified and overexpressed in a variety of cancers, including prostate and breast cancer. Overexpression of EZH2 has been associated with the invasion and progression of malignant cancers, especially with the progression of prostate cancer. Here, we review the structure and biological function of EZH2, especially focused on its activities in the tumorigenesis. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：474 / 477

页数：4

共 50 条

[41] HISTONE METHYLTRANSFERASE ENHANCER OF ZESTE HOMOLOG 2 REGULATES SCHWANN CELL DIFFERENTIATION
Heinen, A.
Tzekova, N.
Graffmann, N.
Torres, K. J.
Uhrberg, M.
Hartung, H. -P.
Kuery, P.
GLIA, 2013, 61 : S140 - S140
[42] Enhancer of Zeste Homolog 2 (EZH2) in Malignant Progression of Gallbladder Carcinoma
Behera, Gayatri
Mitra, Suvradeep
Mishra, Tushar S.
Purkait, Suvendu
JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (03) : 1029 - 1034
[43] Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia
Shi, Yingfeng
Xu, Liuqing
Tao, Min
Fang, Lu
Lu, Jiasun
Gu, Hongwei
Ma, Shuchen
Lin, Tao
Wang, Yi
Bao, Wenfang
Qiu, Andong
Zhuang, Shougang
Liu, Na
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (03) : F488 - F505
[44] Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer
Ishikawa, S.
Hayashi, H.
Kinoshita, K.
Abe, M.
Kuroki, H.
Tokunaga, R.
Tomiyasu, S.
Tanaka, H.
Sugita, H.
Arita, T.
Yagi, Y.
Watanabe, M.
Hirota, M.
Baba, H.
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (11) : 2528 - 2536
[45] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
Hibino, S.
Saito, Y.
Muramatsu, T.
Otani, A.
Kasai, Y.
Kimura, M.
Saito, H.
ONCOGENESIS, 2014, 3 : e104 - e104
[46] Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
S Hibino
Y Saito
T Muramatsu
A Otani
Y Kasai
M Kimura
H Saito
Oncogenesis, 2014, 3 : e104 - e104
[47] Enhancer of zeste homolog 2 (EZH2) expression in G1-G2 Pancreatic Neuroendocrine Tumor (pNET)
Marconcini, R.
Faviana, P.
Campani, D.
Galli, L.
Antonuzzo, A.
Falcone, A.
Ricci, S.
ANNALS OF ONCOLOGY, 2016, 27
[48] Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
Chen, Shuling
Huang, Lixia
Sun, Kaiyu
Wu, Dexi
Li, Minrui
Li, Manying
Zhong, Bihui
Chen, Minhu
Zhang, Shenghong
PLOS ONE, 2015, 10 (05):
[49] Recent Advances in enhancer of zeste homolog 2 Inhibitors: Structural insights and therapeutic applications
Cao, Ruolin
Ni, Jiayang
Zhang, Xiaoyu
Qi, Minggang
Zhang, Zhen
Liu, Zhongbo
Chen, Guoliang
BIOORGANIC CHEMISTRY, 2025, 154
[50] Enhancer of Zeste Homolog 2 Overexpression Has a Role in the Development of Anaplastic Thyroid Carcinomas
Borbone, Eleonora
Troncone, Giancarlo
Ferraro, Angelo
Jasencakova, Zuzana
Stojic, Lovorka
Esposito, Francesco
Hornig, Nadine
Fusco, Alfredo
Orlando, Valerio
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 1029 - 1038

← 1 2 3 4 5 →